Chemical Name: 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile
Biological ActivityPotent, reversible non-steroidal aromatase inhibitor (IC50 = 11.5 nM). Displays antitumor effects in several animal models. Suppresses the endogenous aromatase-induced proliferation of MCF-7 cells.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.
Mitropoulou et al.
Highly selective inhbition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor.
Bhatnagar et al.
J.Steroid Biochem.Mol.Biol., 1990;37:1021
The discovery and mechanism of action of letr.
Breast Cancer Res.Treat., 2007;105:7
Citations for Letrozole
The citations listed below are publications that use Tocris products. Selected citations for Letrozole include:
3 Citations: Showing 1 - 3
Isolation and characterization of a new naturally immortalized human breast carcinoma cell line, KAIMRC1.
Authors: Ali Et al.
BMC Cancer 2017;17:803
OOE synthesized by female neurons generates sex differences in neuritogenesis.
Authors: Ruiz-Palmero Et al.
Scientific Reports 2016;6:31891
Endogenous 17β-OE is required for activity-dependent long-term potentiation in the striatum: interaction with the DArgic system.
Authors: Tozzi Et al.
Front Cell Neurosci 2015;9:192
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for Letrozole
There are currently no reviews for this product. Be the first to review Letrozole and earn rewards!
Have you used Letrozole?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image